VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $541,190 | -66.0% | 23,257 | -63.0% | 0.00% | -75.0% |
| Q4 2022 | $1,592,632 | +29.4% | 62,925 | -1.5% | 0.01% | +33.3% |
| Q3 2022 | $1,231,000 | +212.4% | 63,874 | +313.2% | 0.01% | +200.0% |
| Q2 2022 | $394,000 | -61.9% | 15,460 | -61.5% | 0.00% | -50.0% |
| Q1 2022 | $1,033,000 | +39.0% | 40,149 | +126.2% | 0.00% | +33.3% |
| Q4 2021 | $743,000 | +52.9% | 17,752 | +58.9% | 0.00% | +50.0% |
| Q3 2021 | $486,000 | -8.0% | 11,171 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $528,000 | -12.4% | 11,161 | -5.1% | 0.00% | -33.3% |
| Q1 2021 | $603,000 | -10.4% | 11,761 | -53.2% | 0.00% | 0.0% |
| Q4 2020 | $673,000 | +49.9% | 25,114 | +92.0% | 0.00% | +50.0% |
| Q3 2020 | $449,000 | – | 13,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |